Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance

Author： Zanger Ulrich M   Klein Kathrin   Saussele Tanja   Blievernicht Julia   H Hofmann Marco   Schwab Matthias  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.8, Iss.7, 2007-07, pp. : 743-759

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Molecular Characterization of CYP2B6 Substrates

By  

Current Drug Metabolism, Vol. 9, Iss. 5, 2008-06 ,pp. : 363-373

Bentham Science Publishers

Access to resources Recommend Favorite

CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene

By Skierka Jennifer M   Walker Denise L   Peterson Sandra E   O’Kane Dennis J   Black John Logan  

Pharmacogenomics, Vol. 13, Iss. 8, 2012-06 ,pp. : 951-954

Future Medicine

Access to resources Recommend Favorite

The Pharmacogenetics of CYP2C9 and CYP2C19: Ethnic Variation and Clinical Significance

By  

Current Clinical Pharmacology, Vol. 2, Iss. 1, 2007-01 ,pp. : 93-109

Bentham Science Publishers

Access to resources Recommend Favorite

Common and Distinct Interactions of Chemical Inhibitors with Cytochrome P450 CYP1A2, CYP2A6 and CYP2B6 Enzymes

By  

Drug Metabolism Letters, Vol. 10, Iss. 1, 2016-03 ,pp. : 56-64

Bentham Science Publishers

Access to resources Recommend Favorite

CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 Polymorphisms in Two Bantu-Speaking Populations from Cameroon and South Africa: Implications for Global Pharmacogenetics

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 1, 2012-03 ,pp. : 43-53

Bentham Science Publishers

Access to resources Recommend Favorite